Metal-Organic Frameworks

Ultrasound triggers porous nanoparticles to attack tumors in mice

Metal-organic framework forms particle-embedded porphyrin-zinc complexes that generate reactive oxygen species

by Mark Peplow, special to C&EN
April 25, 2018 | APPEARED IN VOLUME 96, ISSUE 18

Credit: Adv. Mater.
These MOF-derived nanoparticles, roughly 140 nm across, contain porphyrin-zinc units that can generate reactive oxygen species from water when hit by ultrasound.

Metal-organic frameworks (MOFs) are already famed for their ability to store and separate gases, but there is growing interest in their potential medical applications. Chinese researchers have now converted a MOF into nanoparticles that harness the power of ultrasound to kill tumor cells in mice (Adv. Mater. 2018, DOI: 10.1002/adma.201800180).

This general approach to attacking cancer is called sonodynamic cancer therapy, and it relies on compounds that are activated by a targeted burst of ultrasound. The sound waves prompt the compounds, known as sonosensitizers, to generate reactive oxygen species that destroy cancer cells in the immediate vicinity, while avoiding systemic side effects.

Credit: Adv. Mater. / Liu, H. et al.
MOF-derived nanoparticles help to generate cavitation bubbles (roughly 0.1 mm across) in water when blasted with ultrasound. Movie shot at 12,000 frames per second.

The strategy is similar to light-based photodynamic therapy, but ultrasound can penetrate deeper into tissue than light, so the strategy, in principle, could treat more inaccessible tumors. Although the technology has been tested in a handful of patients, the field is still in its infancy. “There are very few groups working on it,” says Nikolitsa Nomikou, who develops sonodynamic therapy agents at University College London and was not involved in the new research.

Among the most widely tested sonosensitizers are porphyrin derivatives, which researchers co-opted from photodynamic therapy. These compounds can produce a lot of reactive oxygen species but usually have poor water solubility and tend to be metabolized quickly by the body. Various inorganic nanoparticle sonosensitizers are more stable, but offer relatively poor yields of reactive oxygen species.

Huiyu Liu at the Beijing University of Chemical Technology and colleagues have now combined some of the key benefits of each class of sonosensitizer into a single material that avoids their main pitfalls.

The team’s sonosensitizer is based on a MOF called ZIF-8, which contains a porous lattice of zinc ions held together by imidazolate linkers. After coating ZIF-8 particles with a protective shell of silica to prevent them from sticking together, the researchers heated them at 800 °C for two hours. The MOF transformed into porous carbon nanoparticles that contained zinc coordinated to porphyrin-like rings. Then the researchers stripped away the silica shell and decorated the 140 nm-wide particles with polyethylene glycol to improve their solubility and transport in the body.

A solution of the nanoparticles in water produced large amounts of hydroxyl radicals and singlet oxygen when hit with ultrasound. “The hydroxyl radical generation efficiency is higher than porphyrin-zinc,” says Xueting Pan, a member of the research team.

The precise mechanism involved in generating reactive oxygen species with ultrasound remains one of the big unanswered questions in the field. Previous studies have shown that it involves the formation of tiny bubbles during the ultrasound blast, Pan says. When these bubbles collapse, they can generate flashes of light that excite electrons within a sonosensitizer, ultimately triggering the formation of reactive oxygen species, Nomikou says. The collapsing bubbles can also create jets of fluid that may damage tumor cells, she adds.

The Beijing team found that their nanoparticles’ porous structure helped to seed bubble formation, which may partly explain their success in tests on mice with implanted breast cancer tumors.


After injecting the mice with a solution of the particles, the researchers bombarded the tumor site with 1 MHz ultrasound for five minutes, repeated the ultrasound treatment after 3 days, and then followed the mice’s progress for another 15 days. By the end of that period, the treatment had killed 85% of tumor cells, with no observable side effects or damage to major organs. Ultrasound alone killed just 35% of tumor cells, while injected sonosensitizer particles without any applied ultrasound reduced tumor cell count by just 15%. “It’s very exciting and innovative,” Nomikou says. “It is a system with potential.”


This article has been sent to the following recipient:

Leave A Comment

*Required to comment